The Janus kinase 1/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis

被引：0
|
作者：
Christian S. Thudium
Anne C. Bay-Jensen
Suntara Cahya
Ernst R. Dow
Morten A. Karsdal
Alisa E. Koch
Wenling Zhang
Robert J. Benschop
机构：
[1] Nordic Bioscience,
[2] Biomarkers and Research,undefined
[3] Eli Lilly and Company,undefined
来源：
Arthritis Research & Therapy | / 22卷
关键词：
Biomarkers; Baricitinib; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor
    Charles-Schoeman, Christina
    Wicker, Pierre
    Gonzalez-Gay, Miguel A.
    Boy, Mary
    Zuckerman, Andrea
    Soma, Koshika
    Geier, Jamie
    Kwok, Kenneth
    Riese, Richard
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 46 (03) : 261 - 271
  • [32] Increased risk of Pneumocystis jirovecii colonization in rheumatoid arthritis patients on biologics and Janus kinase inhibitor
    Huang, Ya-Chun
    Lee, Nan-Yao
    Weng, Meng-Yu
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2025, 58 (01) : 112 - 119
  • [33] Development of severe thrombocytopenia with TAFRO syndrome-like features in a patient with rheumatoid arthritis treated with a Janus kinase inhibitor A case report
    Kadoba, Keiichiro
    Waki, Daisuke
    Nishimura, Keisuke
    Mukoyama, Hiroki
    Saito, Rintaro
    Murabe, Hiroyuki
    Yokota, Toshihiko
    MEDICINE, 2020, 99 (42) : E22793
  • [34] Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population
    Hall, Stephen
    Nash, Peter
    Rischmueller, Maureen
    Bossingham, David
    Bird, Paul
    Cook, Nicola
    Witcombe, David
    Soma, Koshika
    Kwok, Kenneth
    Thirunavukkarasu, Krishan
    RHEUMATOLOGY AND THERAPY, 2018, 5 (02) : 383 - 401
  • [35] Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme
    Curtis, Jeffrey R.
    Lee, Eun Bong
    Kaplan, Irina V.
    Kwok, Kenneth
    Geier, Jamie
    Benda, Birgitta
    Soma, Koshika
    Wang, Lisy
    Riese, Richard
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (05) : 831 - 841
  • [36] Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population
    Stephen Hall
    Peter Nash
    Maureen Rischmueller
    David Bossingham
    Paul Bird
    Nicola Cook
    David Witcombe
    Koshika Soma
    Kenneth Kwok
    Krishan Thirunavukkarasu
    Rheumatology and Therapy, 2018, 5 : 383 - 401
  • [37] BARICITINIB IN THE TREATMENT OF PATIENTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS IN CHINA: 24-WEEK RESULTS OF POSTMARKETING SAFETY STUDY
    Wu, C. Y.
    Wang, Q.
    Shi, J.
    Zhang, X.
    Du, R.
    Gu, J.
    Liu, Q. H.
    Yu, J.
    Xu, J. W.
    Zhang, Y. J.
    Zhu, H.
    Li, M.
    Zeng, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1418 - 1418
  • [38] Drug survival and change of disease activity using a second janus kinase inhibitor in patients with difficult-to-treat rheumatoid arthritis who failed to a janus kinase inhibitor and subsequent biologics
    Kwon, Oh Chan
    Choi, Wonho
    Ahn, Soo Min
    Oh, Ji Seon
    Hong, Seokchan
    Lee, Chang-Keun
    Yoo, Bin
    Park, Min-Chan
    Kim, Yong-Gil
    ADVANCES IN RHEUMATOLOGY, 2024, 64 (01)
  • [39] Hypereosinophilic syndrome—a rare adverse event of anti-cytokine treatment in rheumatoid arthritis resolved after Janus kinase inhibitor therapy
    Emőke Šteňová
    Lenka Tarabčáková
    Pavel Babál
    Stela Kašperová
    Clinical Rheumatology, 2020, 39 : 3507 - 3510
  • [40] Tofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis Pooled efficacy and safety analyses
    Lomonte, Andrea B. V.
    Radominski, Sebastiao C.
    Marcolino, Flora M. D.
    Brenol, Claiton V.
    Zerbini, Cristiano A. F.
    Garcia, Erika G.
    Akylbekova, Ermeg L.
    Rojo, Ricardo
    Ponce de Leon, Dario
    MEDICINE, 2018, 97 (31)
12345